1. Home
  2. BSX vs DHR Comparison

BSX vs DHR Comparison

Compare BSX & DHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$95.58

Market Cap

137.8B

Sector

Health Care

ML Signal

HOLD

Logo Danaher Corporation

DHR

Danaher Corporation

HOLD

Current Price

$230.40

Market Cap

162.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSX
DHR
Founded
1979
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
137.8B
162.7B
IPO Year
1992
N/A

Fundamental Metrics

Financial Performance
Metric
BSX
DHR
Price
$95.58
$230.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
18
Target Price
$125.88
$248.47
AVG Volume (30 Days)
9.5M
3.5M
Earning Date
02-04-2026
01-28-2026
Dividend Yield
N/A
0.56%
EPS Growth
54.68
N/A
EPS
1.87
4.87
Revenue
$19,349,000,000.00
$24,268,000,000.00
Revenue This Year
$21.05
$3.76
Revenue Next Year
$11.44
$4.06
P/E Ratio
$51.37
$47.33
Revenue Growth
21.61
2.21
52 Week Low
$85.98
$171.00
52 Week High
$109.50
$258.23

Technical Indicators

Market Signals
Indicator
BSX
DHR
Relative Strength Index (RSI) 46.92 58.31
Support Level $95.55 $229.23
Resistance Level $96.48 $231.73
Average True Range (ATR) 1.69 4.07
MACD 0.38 0.05
Stochastic Oscillator 77.37 78.14

Price Performance

Historical Comparison
BSX
DHR

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

About DHR Danaher Corporation

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.

Share on Social Networks: